SEARCH

SEARCH BY CITATION

References

  • 1
    Lohner, K. (2001) Development of Novel Antimicrobial Agents: Emerging Strategies. Horizon Scientific Press, Norfolk, England.
  • 2
    Epand, R.M. & Vogel, H.J. (1999) Diversity of antimicrobial peptides and their mechanisms of action. Biochim. Biophys. Acta 1462, 1128.
  • 3
    Hamuro, Y., Schneider, J.P. & DeGrado, W.F. (1999) De novo design of antibacterial beta-peptides. J. Am. Chem. Soc. 121, 1220012201.
  • 4
    Arvidsson, P.I., Frackenpohl, J., Ryder, N.S., Liechty, B., Petersen, F., Zimmermann, H., Camenisch, G.P., Woessner, R. & Seebach, D. (2001) On the antimicrobial and hemolytic activities of amphiphilic beta-peptides. Chembiochem. 2, 771773.
  • 5
    Liu, D. & DeGrado, W.F. (2001) De novo design, synthesis and characterization of antimicrobial-β-peptides. J. Am. Chem. Soc. 123, 75537559.
  • 6
    Cheng, R.P., Gellman, S.H. & DeGrado, W.F. (2001) Beta-peptides: from structure to function. Chem. Rev. 101, 32193232.
  • 7
    Porter, E.A., Wang, X., Lee, H.S., Weisblum, B. & Gellman, S.H. (2000) Non-haemolytic beta-amino-acid oligomers. Nature 404, 565.
  • 8
    Porter, E.A., Weisblum, B. & Gellman, S.H. (2002) Mimicry of host-defense peptides by unnatural oligomers: Antimicrobial beta-peptides. J. Am. Chem. Soc. 124, 73247330.
  • 9
    Hintermann, T. & Seebach, D. (1997) The biological stability of beta–peptides: No interactions between alpha- and beta-peptidic structures. Chimia 51, 244247.
  • 10
    Seebach, D., Abele, S., Schreiber, J.V., Martinoni, B., Nussbaum, A.K., Schild, H., Schulz, H., Hennecke, H., Woessner, R. & Bitsch, F. (1998) Biological and pharmacokinetic studies with beta-peptides. Chimia 52, 734739.
  • 11
    Matsuzaki, K., Nakamura, A., Murase, O., Sugishita, K., Fujii, N. & Miyajima, K. (1997) Modulation of magainin 2–lipid bilayer interactions by peptide charge. Biochemistry 36, 21042111.
  • 12
    Appella, D.H., Christianson, L.A., Klein, D.A., Powell, D.R., Huang, X., Barchi, J.J. Jr & Gellman, S.H. (1997) Residue-based control of helix shape in beta-peptide oligomers. Nature 387, 381384.
  • 13
    Appella, D.H., Christianson, L.A., Klein, D.A., Richards, M.R., Powell, D.R. & Gellman, S.H. (1999) Synthesis and structural characterization of helix-forming beta-peptides: trans-2-aminocyclopentanecarboxylic acid oligomers. J. Am. Chem. Soc. 121, 75747581.
  • 14
    Barchi, J.J., Huang, X.L., Appella, D.H., Christianson, L.A., Durell, S.R. & Gellman, S.H. (2000) Solution conformations of helix-forming beta-amino acid homooligomers. J. Am. Chem. Soc. 122, 27112718.
  • 15
    Wang, X.F., Espinosa, J.F. & Gellman, S.H. (2000) 12-helix formation in aqueous solution with short beta-peptides containing pyrrolidine-based residues. J. Am. Chem. Soc. 122, 48214822.
  • 16
    Kobayashi, S., Takeshima, K., Park, C.B., Kim, S.C. & Matsuzaki, K. (2000) Interactions of the novel antimicrobial peptide buforin 2 with lipid bilayers: proline as a translocation promoting factor. Biochemistry 39, 86488654.
  • 17
    Matsuzaki, K. (1998) Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim. Biophys. Acta 1376, 391400.
  • 18
    Matsuzaki, K. (1999) Why and how are peptide–lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta 1462, 110.
  • 19
    Shai, Y. & Oren, Z. (2001) From ‘carpet’ mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides. Peptides 22, 16291641.
  • 20
    Lee, H.S., LePlae, P.R., Porter, E.A. & Gellman, S.H. (2001) An efficient route to either enantiomer of orthogonally protected trans-3-aminopyrrolidine-4-carboxylic acid. J. Org. Chem. 66, 35973599.
  • 21
    LePlae, P.R., Umezawa, N., Lee, H.S. & Gellman, S.H. (2001) An efficient route to either enantiomer of trans-2-aminocyclopentanecarboxylic acid. J. Org. Chem. 66, 56295632.
  • 22
    Ames, B.N. (1966) Assay of inorganic phosphate, total phosphate and phosphatases. Methods Enzymol. 8, 115118.
  • 23
    Ellens, H., Bentz, J. & Szoka, F.C. (1985) H+- and Ca2+-induced fusion and destabilization of liposomes. Biochemistry 24, 30993106.
  • 24
    Rajarathnam, K., Hochman, J., Schindler, M. & Ferguson-Miller, S. (1989) Synthesis, location, and lateral mobility of fluorescently labeled ubiquinone 10 in mitochondrial and artificial membranes. Biochemistry 28, 31683176.
  • 25
    Kim, J., Blackshear, P.J., Johnson, J.D. & McLaughlin, S. (1994) Phosphorylation reverses the membrane association of peptides that correspond to the basic domains of MARCKS and neuromodulin. Biophys. J. 67, 227237.
  • 26
    Peitzsch, R.M. & McLaughlin, S. (1993) Binding of acylated peptides and fatty acids to phospholipid vesicles: pertinence to myristoylated proteins. Biochemistry 32, 1043610443.
  • 27
    Ladokhin, A.S., Selsted, M.E. & White, S.H. (1997) Bilayer interactions of indolicidin, a small antimicrobial peptide rich in tryptophan, proline, and basic amino acids. Biophys. J. 72, 794805.
  • 28
    Epand, R.M. (1985) Diacylglycerols, lysolecithin, or hydrocarbons markedly alter the bilayer to hexagonal phase transition temperature of phosphatidylethanolamines. Biochemistry 24, 70927095.
  • 29
    Matsuzaki, K., Sugishita, K., Ishibe, N., Ueha, M., Nakata, S., Miyajima, K. & Epand, R.M. (1998) Relationship of membrane curvature to the formation of pores by magainin 2. Biochemistry 37, 1185611863.
  • 30
    Chen, H.C., Brown, J.H., Morell, J.L. & Huang, C.M. (1988) Synthetic magainin analogues with improved antimicrobial activity. FEBS Lett. 236, 462466.
  • 31
    Applequist, J., Bode, K.A., Appella, D.H., Christianson, L.A. & Gellman, S.H. (1998) Theoretical and experimental circular dichroic spectra of the novel helical foldamer poly[(1R,2R)-trans-2-aminocyclopentanecarboxylic acid]. J. Am. Chem. Soc. 120, 48914892.
  • 32
    Lee, H.S., Syud, F.A., Wang, X.F. & Gellman, S.H. (2001) Diversity in short beta-peptide 12-helices: High-resolution structural analysis in aqueous solution of a hexamer containing sulfonylated pyrrolidine residues. J. Am. Chem. Soc. 123, 77217722.
  • 33
    Epand, R.F. & Scheraga, H.A. (1968) The helix-coil transition of poly-l-lysine in methanol-water solvent mixtures. Biopolymers 6, 13831386.
  • 34
    Unger, T., Oren, Z. & Shai, Y. (2001) The effect of cyclization of magainin 2 and melittin analogues on structure, function, and model membrane interactions: implication to their mode of action. Biochemistry 40, 63886397.
  • 35
    Matsuzaki, K., Murase, O. & Miyajima, K. (1995) Kinetics of pore formation by an antimicrobial peptide, magainin 2, in phospholipid bilayers. Biochemistry 34, 1255312559.
  • 36
    Avrahami, D., Oren, Z. & Shai, Y. (2001) Effect of multiple aliphatic amino acids substitutions on the structure, function, and mode of action of diastereomeric membrane active peptides. Biochemistry 40, 1259112603.
  • 37
    Baker, M.A., Maloy, W.L., Zasloff, M. & Jacob, L.S. (1993) Anticancer efficacy of magainin 2 and analogue peptides. Cancer Res. 53, 30523057.
  • 38
    Cruciani, R.A., Barker, J.L., Zasloff, M., Chen, H.C. & Colamonici, O. (1991) Antibiotic magainins exert cytolytic activity against transformed cell lines through channel formation. Proc. Natl Acad. Sci. USA 88, 37923796.
  • 39
    Haimovich, B. & Tanaka, J.C. (1995) Magainin-induced cytotoxicity in eukaryotic cells: kinetics, dose–response and channel characteristics. Biochim. Biophys. Acta 1240, 149158.
  • 40
    Jacob, L. & Zasloff, M. (1994) Potential therapeutic applications of magainins and other antimicrobial agents of animal origin. Ciba Found. Symp. 186, 197216.
  • 41
    Ohsaki, Y., Gazdar, A.F., Chen, H.C. & Johnson, B.E. (1992) Antitumor activity of magainin analogues against human lung cancer cell lines. Cancer Res. 52, 35343538.
  • 42
    Shin, S.Y., Lee, M.K., Kim, K.L. & Hahm, K.S. (1997) Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides. J. Pept. Res. 50, 279285.
  • 43
    Shin, S.Y., Kang, J.H., Jang, S.Y., Kim, Y., Kim, K.L. & Hahm, K.S. (2000) Effects of the hinge region of cecropin A(1–8)-magainin 2 (1–12), a synthetic antimicrobial peptide, on liposomes, bacterial and tumor cells. Biochim. Biophys. Acta 1463, 209218.
  • 44
    Soballe, P.W., Maloy, W.L., Myrga, M.L., Jacob, L.S. & Herlyn, M. (1995) Experimental local therapy of human melanoma with lytic magainin peptides. Int. J. Cancer 60, 280284.
  • 45
    Westerhoff, H.V., Zasloff, M., Rosner, J.L., Hendler, R.W., De Waal, A., Vaz, G.A., Jongsma, P.M., Riethorst, A. & Juretic, D. (1995) Functional synergism of the magainins PGLa and magainin 2 in Escherichia coli, tumor cells and liposomes. Eur. J. Biochem. 228, 257264.
  • 46
    Breukink, E., Bonev, B.B., Wiedemann, I., Sahl, H.G., Watts, A. & de Kruijff, B. (2001) Specific interaction of the lantibiotic nisin with lipid II leads to highly efficient pore formation. Biophys. J. 80, 2A.
  • 47
    Breukink, E., Ganz, P., de Kruijff, B. & Seelig, J. (2000) Binding of nisin Z to bilayer vesicles as determined with isothermal titration calorimetry. Biochemistry 39, 1024710254.
  • 48
    Breukink, E., Wiedemann, I., van Kraaij, C., Kuipers, O.P., Sahl, H.G. & de Kruijff, B. (1999) Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286, 23612364.
  • 49
    Wiedemann, I., Breukink, E., van Kraaij, C., Kuipers, O.P., Bierbaum, G., de Kruijff, B. & Sahl, H.A. (2001) Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J. Biol. Chem. 276, 17721779.
  • 50
    Kobayashi, S., Hirakura, Y. & Matsuzaki, K. (2001) Bacteria-selective synergism between the antimicrobial peptides alpha-helical magainin 2 and cyclic beta-sheet tachyplesin I: toward cocktail therapy. Biochemistry 40, 1433014335.